FDA Approves Furoscix ReadyFlow, a Quick at-Home Injection for Fluid Buildup

The FDA has approved Furoscix ReadyFlow (furosemide subcutaneous injection) for adults with chronic heart failure or chronic kidney disease. It is used to treat edema, which is fluid buildup in the body. Extra fluid can… Read more

Tylenol With Naproxen: New Over-the-Counter Pill for 12-Hour Pain Relief

What Is Tylenol With Naproxen and How Does It Work? The FDA has approved a new combination product, Tylenol with Naproxen, for over-the-counter pain relief in adults and children 12 and older. It is approved… Read more

FDA Approves Pluvicto for Early-Stage Metastatic Prostate Cancer

The FDA has approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to treat adults with a specific type of advanced prostate cancer. It is used for prostate cancer that has spread to other parts of the… Read more

FDA Approves Mucinex 12HR Cold & Fever Multi-Symptom for Cold and Flu Relief

What Is Mucinex 12HR Cold & Fever Multi-Symptom, and How Does It Work? The FDA has approved Mucinex 12HR Cold & Fever Multi-Symptom. It is an over-the-counter medicine used to relieve symptoms of the common… Read more

FDA Approves Orzeyful (Oveporexton) for Adults With Narcolepsy Type 1

The FDA has approved Orzeyful (oveporexton) for adults with a long-term sleep disorder called narcolepsy type 1. People with this condition have extreme sleepiness during the day and a hard time focusing or staying awake.… Read more

FDA Approves Zenbexus Combination for Multiple Myeloma

The FDA has approved Zenbexus (iberdomide) to treat adults with multiple myeloma. Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. It is used for people whose cancer… Read more

FDA Approves Pasatru for Adults With Rare Bone Disease

The FDA has approved Pasatru (garetosmab) for adults with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare genetic disease. It causes muscles, tendons, and ligaments to gradually turn into bone outside the normal skeleton. Over… Read more

FDA Approves Genglycos, First Gene Therapy for Glycogen Storage Disease Type 1a

Genglycos (pariglasgene brecaparvovec) is FDA approved for adults and children 8 and older who have glycogen storage disease type 1a (GSD1a). GSD1a is a rare genetic disorder caused by a missing enzyme called glucose-6-phosphatase (G6Pase).… Read more

FDA Approves Ziihera Combinations for Advanced Stomach and Esophageal Cancers

The FDA has approved Ziihera (zanidatamab-hrii) to treat adults with advanced or spreading gastroesophageal adenocarcinoma (GEA). GEA includes cancers of the stomach, the esophagus, and the area where the stomach and esophagus meet. This drug… Read more

FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia

The FDA has approved Imaavy (nipocalimab-aahu) to treat adults and children 12 and older who have warm autoimmune hemolytic anemia (wAIHA). It is for people who are taking or have taken steroid medicines for their… Read more